Training Details

Event Dates and Timeframe
  • Thursday, May 28, 2020
    • 10:00 AM to 11:00 AM

Location

Zoom
https://zoom.us

Cost Range

FREE

Host and Instructor

Host: National Council for Behavioral Health
Instructor: Jonathan Craig Allen, M.D., FASAM, medical director at Rushford

Description

Join us for Treatment and Engagement Strategies for Youth and Young Adults with Opioid Use Disorder, a webinar hosted by the National Council for Behavioral Health and the Providers Clinical Support System (PCSS) on May 28 from 2-3 p.m. ET. The presenter will be Jonathan Craig Allen, M.D., FASAM, medical director at Rushford.



Adolescents and young adults who use opioids, especially in combination with alcohol, could be at higher risk for overdose during the COVID-19 pandemic. Yet, are one-tenth as likely to get appropriate treatment for opioid use disorder (OUD) than those over the age of 25. Medications for opioid use disorder (MOUD), considered first line treatments, decrease the risk of overdose death from 50-80%. Nonetheless, a study recently published in JAMA Pediatrics looked found that less than 2% of adolescents and young adults received one of the three FDA-approved medications. This may be due to lack of education and training for medical providers, lack of clinically appropriate care available in specialty settings or concerns about using these medications with this age group. This webinar will provide education and guidance to interested providers about how to effectively treat and engage adolescents and young adults in opioid use disorder treatment.

Learning Objectives:

Questions? Contact KC Wu at KCW@TheNationalCouncil.org

For more information on the Providers Clinical Support System, visit pcssNOW.org

Funding for this initiative was made possible (in part) by grant no. 1H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.